SSelectStock

GPTHEALTHGPT Healthcare Limited

Healthcare · Medical Care Facilities · NSE · as of 2026-09-11 (delayed ~30 min in market hours)

GPT Healthcare Limited owns and operates a chain of multispecialty hospitals under the ILS Hospitals brand name in India. The company offers healthcare services, including internal medicine and diabetology; nephrology, such as renal transplants; laparoscopic and general surgery; gynecology and obstetrics; critical care; gastroenterology; orthopedics and joint replacement; interventional cardiology; neurology; neurosurgery; pediatrics; neonatology; robotic-assisted surgery; bariatric surgery; hematology; psychology; dermatology; and ENT services. It also operates clinics and pharmacies; provides academic and diagnostic services; and sale of pharmaceutical products. The company was incorporated in 1989 and is based in Kolkata, India. GPT Healthcare Limited operates as a subsidiary of GPT Sons Pvt. Ltd.

159.38
1.18%
70Strong

Mkt Cap
₹1,311 Cr
P/E
30.4
P/B
4.9
Div Yield
1.58%
52W High
₹175.00
52W Low
₹115.00

Price & Volume

Loading chart…

Key Ratios

Market Cap (₹ cr)1,310.70
P/E30.36
P/B4.91
PEG2.18
ROE %16.32
ROCE %16.30
Debt / Equity0.34
EPS5.25
Revenue Growth %24.60
Profit Growth %13.70
Dividend Yield %1.58
Promoter Holding %66.77
FII Holding %7.42
DII Holding %
Beta0.46

“—” means the figure isn't meaningful or isn't published for this company: ROE and Debt/Equity are undefined when shareholder equity is negative (check P/B — negative means negative equity), and DII/MF holding splits aren't provided by our current data source.

Active Pattern Signals

BUYConviction 81%

Why buy

  • Revenue growth: 24.6% YoY
  • ROE: 16.3%
  • ROCE: 16.3%
  • RSI: 56
  • MACD: bullish
  • Price vs EMA21: above
  • Pullback to 21-EMA signal (setup quality 70%)

Bull case

  • Revenue growth: 24.6% YoY
  • ROE: 16.3%
  • ROCE: 16.3%
  • RSI: 56

Bear case

  • Supertrend: bearish
  • Volume: 1.0x 20-day average
  • Volume trend: 0.7x baseline
  • Liquidity: ₹1.6 cr avg turnover

Key risks

  • Supertrend: bearish
  • Volume: 1.0x 20-day average

Algorithmic analysis for research only — not SEBI-registered investment advice.

Trade Plan

Entry (CMP)
₹159.38
Stop Loss
₹147.66
risk 7.4%
Target 1 (1.5R)
₹176.96
+11.0%
Target 2 (3R)
₹194.54
+22.1%
Support (20d)
₹148.61
Resistance (52w)
₹175.00
Risk : Reward
1 : 1.5 → 1 : 3
risking ₹11.72/share
ATR (volatility)
₹4.69
avg daily range

Stop = 20-day support with a 2.5×ATR risk cap (ATR ₹4.69). Levels recompute on every data refresh. Position sizing and execution are yours — this is analysis, not advice.

Score Breakdown

Fundamental78
Technical67
Momentum70
Risk (safety)60

Peers — Healthcare

GKSL 1.23%
79
NEPHROPLUS 2.42%
74
KOVAI 1.41%
73
METROPOLIS 1.70%
73
SAILIFE 0.38%
73
VIJAYA 0.21%
72